Adam Fein of Drug Channels to Share Insights at Access! 2021 @accessiblemeds
Adam Fein of Drug Channels to Share Insights at Access! 2021  @accessiblemeds
Uploaded April 2021 | Updated November 2026, 3 hours ago
Join industry expert Adam J. Fein, PhD, as he helps the industry navigate this challenging and dynamic period in U.S. drug channels. During this interactive virtual session, Dr. Fein will explain the key trends reshaping U.S. drug channels, examine the emergence of organized market access channels, highlight business and marketing implications for generic and biosimilar medicines, and discuss strategic implications and the industry outlook. Dr. Fein will also be taking your questions during his session on Thursday, May 27. #Access2021

Learn more or register at: access.accessiblemeds.org
Adam Fein of Drug Channels to Share Insights at Access! 2021AAM Board Chair Christine Baeder at GRx+Biosims 2022A Blueprint for Enhancing the Security of the U.S. Pharmaceutical Supply ChainMichelles Story - #medswithinreachOverall Savings Generated by Generics and Biosimilars in 2021 #GRxBiosimsSavingsReportCOVID Response: AAM Board Chair Alok SonigAAM All Access Promo: Managing Drug Shortages Part 1Dougs Story - #medswithinreach35 Year Anniversary of Generic MedicinesGDUFA/BsUFA User Fees ExplainedSavings from Biosimilars since 2015 #GRxBiosimsSavingsReportBriefing: How NAFTA/Trade Policy Proposals Undermine Trump Administration Drug Pricing Blueprint
Association for Accessible Medicines |

Adam Fein of Drug Channels to Share Insights at Access! 2021

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER